Trial Outcomes & Findings for Pancreaticobiliary Reflux in Patients Without Cholelithiasis (NCT NCT00890201)
NCT ID: NCT00890201
Last Updated: 2010-12-17
Results Overview
Normal values of lipase and amylase in gallbladder bile should be zero
COMPLETED
197 participants
24 hours
2010-12-17
Participant Flow
Patients recruited at the Department of Surgery of the Hospital de La Serena from January 2009 to July 2009
Patients submitted to elective cholecystectomy for symptomatic gallstone disease, older than 16 years of age and patients submitted to elective gastrectomy for gastric cancer harboring normal gallbladders (without gallstones), were included in this trial. Patients within any other clinical situation were excluded
Participant milestones
| Measure |
Normal Gallbladder
Patients with normal gallbladder (without gallstones) evidenced by preoperative ultrasonography (and postoperative biopsy) submitted to elective gastroesophageal surgery (gastrectomy for gastric cancer, bariatric surgery or esophageal surgery such as Nissen plicature or miotomy for achalasia).
The pancreaticobiliary junction must be normal as evidenced by intraoperative cholangiography. Preoperative values of amylase and lipase must be normal.
|
Gallbladder With Gallstones
Patients submitted to elective cholecystectomy for diseased gallbladders (gallbladder with gallstones evidenced by preoperative ultrasound).
The pancreaticobiliary junction must be normal as evidenced by intraoperative cholangiography and the preoperative amylase and lipase levels must also be normal.
|
|---|---|---|
|
Overall Study
STARTED
|
38
|
159
|
|
Overall Study
COMPLETED
|
33
|
103
|
|
Overall Study
NOT COMPLETED
|
5
|
56
|
Reasons for withdrawal
| Measure |
Normal Gallbladder
Patients with normal gallbladder (without gallstones) evidenced by preoperative ultrasonography (and postoperative biopsy) submitted to elective gastroesophageal surgery (gastrectomy for gastric cancer, bariatric surgery or esophageal surgery such as Nissen plicature or miotomy for achalasia).
The pancreaticobiliary junction must be normal as evidenced by intraoperative cholangiography. Preoperative values of amylase and lipase must be normal.
|
Gallbladder With Gallstones
Patients submitted to elective cholecystectomy for diseased gallbladders (gallbladder with gallstones evidenced by preoperative ultrasound).
The pancreaticobiliary junction must be normal as evidenced by intraoperative cholangiography and the preoperative amylase and lipase levels must also be normal.
|
|---|---|---|
|
Overall Study
Protocol Violation
|
5
|
56
|
Baseline Characteristics
Pancreaticobiliary Reflux in Patients Without Cholelithiasis
Baseline characteristics by cohort
| Measure |
Normal Gallbladder
n=38 Participants
Patients with normal gallbladder (without gallstones) evidenced by preoperative ultrasonography (and postoperative biopsy) submitted to elective gastroesophageal surgery (gastrectomy for gastric cancer, bariatric surgery or esophageal surgery such as Nissen plicature or miotomy for achalasia).
The pancreaticobiliary junction must be normal as evidenced by intraoperative cholangiography. Preoperative values of amylase and lipase must be normal.
|
Gallbladder With Gallstones
n=159 Participants
Patients submitted to elective cholecystectomy for diseased gallbladders (gallbladder with gallstones evidenced by preoperative ultrasound).
The pancreaticobiliary junction must be normal as evidenced by intraoperative cholangiography and the preoperative amylase and lipase levels must also be normal.
|
Total
n=197 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
33 Participants
n=5 Participants
|
149 Participants
n=7 Participants
|
182 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
5 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
|
Age Continuous
|
55.4 years
STANDARD_DEVIATION 10 • n=5 Participants
|
43.4 years
STANDARD_DEVIATION 12.6 • n=7 Participants
|
46.3 years
STANDARD_DEVIATION 13 • n=5 Participants
|
|
Sex: Female, Male
Female
|
21 Participants
n=5 Participants
|
19 Participants
n=7 Participants
|
40 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
17 Participants
n=5 Participants
|
140 Participants
n=7 Participants
|
157 Participants
n=5 Participants
|
|
Region of Enrollment
Chile
|
38 participants
n=5 Participants
|
159 participants
n=7 Participants
|
197 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 24 hoursPopulation: The number of participants analyzed was determined by the number of participants that matched the inclusion criteria. As posted elsewhere some participants were excluded from this analysis based in the exclusion criteria of the protocol.
Normal values of lipase and amylase in gallbladder bile should be zero
Outcome measures
| Measure |
Normal Gallbladder
n=33 Participants
Patients with normal gallbladder (without gallstones) evidenced by preoperative ultrasonography (and postoperative biopsy) submitted to elective gastroesophageal surgery (gastrectomy for gastric cancer, bariatric surgery or esophageal surgery such as Nissen plicature or miotomy for achalasia).
The pancreaticobiliary junction must be normal as evidenced by intraoperative cholangiography. Preoperative values of amylase and lipase must be normal.
|
Gallbladder With Gallstones
n=103 Participants
Patients submitted to elective cholecystectomy for diseased gallbladders (gallbladder with gallstones evidenced by preoperative ultrasound).
The pancreaticobiliary junction must be normal as evidenced by intraoperative cholangiography and the preoperative amylase and lipase levels must also be normal.
|
|---|---|---|
|
Amylase and Lipase Values in Gallbladder Bile
Amylase
|
5.5 mg/dl
Standard Deviation 16.4
|
181.2 mg/dl
Standard Deviation 352
|
|
Amylase and Lipase Values in Gallbladder Bile
Lipase
|
9.5 mg/dl
Standard Deviation 16.6
|
434.8 mg/dl
Standard Deviation 1224
|
SECONDARY outcome
Timeframe: 24 hoursOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 24 hoursOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 24 hoursOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 24 hoursOutcome measures
Outcome data not reported
Adverse Events
Normal Gallbladder
Gallbladder With Gallstones
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Marcelo A. Beltran, M.D. - Department of Surgery - Hospital de La Sererna
Hospital de La Serena
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place